Home Page CW

Our Vision is to lead the development of safe, effective and affordable personalised precision healthcare solutions for inflammatory diseases (IDs) to help individuals to live longer, healthier and happier lives.

Our Mission is to fast-track diagnostic tools and treatments for individuals with chronic inflammatory diseases (cIDs) as well as those vulnerable to poor outcomes from acute inflammatory diseases (aIDs).

Our aim is help increase the quality of life, extend healthspan, reduce sickspan and reduce the cost of care.      Our current focus is on precision healthcare technologies for cIDs of the bowels, brain and skin as well as early identification of vulnerable individuals at high risk of suffering serious sickness or death if they were to be infected with SARS-Cov-2 virus.

We started Avenna to enhance the way healthcare is performed for chronic inflammatory diseases (cIDs).  What we have now for cIDs is really Sickcare. It operates too late – so individuals suffer from inflammation-related tissue and organ damage. And healthcare for cIDs is becoming unaffordable – so all of society suffers.

But it does not have to be this way. There are precision medicine technologies that can detect specific cIDs many years before permanent damage occurs. And some of these technologies are stuck in research labs.

At Avenna we translate the most promising of those research technologies into practical, affordable, accessible tools so individuals and clinicians can find out what cIDs they are developing early on and, through evidence-based, personalised anti -inflammatory protocols, greatly improve their health futures.

To that end, we are developing a suite of tools to aid the translation and clinical testing of precision medicine technology. The Avenna Precision Healthcare System (AvPHS) is a framework for a life-course approach we are using to model, track and improve an individual’s health trajectory.